In vitro and in vivo effects of vanadate on K+-dependent phosphatase activities from subcellular fractions of brain, kidney and liver.
Inhibition of K+-dependent phosphatases by sodium orthovanadate was studied in the subcellular fractions of brain, kidney and liver from male Sprague-Dawley rats. The concentration required to produce an in vitro phosphatase inhibition of 50% ranged from a low of 0.2 microM in the kidney 900 X g fraction to a peak of 400 microM in the brain soluble fraction. The concentrations required to produce 50% inhibition occurred in the micromolar range for most fractions studied. Injection of sodium vanadate (i.p., 8 mg/kg) produced phosphatase inhibition in several of the fractions, but not as pronounced as the in vitro treatment. The results indicate that vanadate is a potent inhibitor of phosphatase activity in vitro, and may have similar potential in vivo.